Financial results - NEUROVAL MED SRL

Financial Summary - Neuroval Med Srl
Unique identification code: 36240268
Registration number: J34/326/2016
Nace: 8622
Sales - Ron
17.182
Net Profit - Ron
1.473
Employees
1
Open Account
Company Neuroval Med Srl with Fiscal Code 36240268 recorded a turnover of 2024 of 17.182, with a net profit of 1.473 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Neuroval Med Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - 2.677 6.311 1.676 10.229 7.008 7.184 8.788 11.733 17.182
Total Income - EUR - 2.680 6.314 1.676 10.229 7.008 7.193 8.788 11.733 17.182
Total Expenses - EUR - 226 802 662 4.141 2.270 3.813 13.560 15.299 15.194
Gross Profit/Loss - EUR - 2.454 5.512 1.014 6.087 4.739 3.381 -4.772 -3.566 1.988
Net Profit/Loss - EUR - 2.374 5.323 964 5.781 4.551 3.276 -4.866 -3.684 1.473
Employees - 1 0 0 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 47.3%, from 11.733 euro in the year 2023, to 17.182 euro in 2024. The Net Profit increased by 1.473 euro, from 0 euro in 2023, to 1.473 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Neuroval Med Srl

Rating financiar

Financial Rating -
NEUROVAL MED SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Neuroval Med Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Neuroval Med Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Neuroval Med Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Neuroval Med Srl - CUI 36240268

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - 104 0 0 94 0 0 0 0 0
Current Assets - 2.394 6.708 7.747 13.639 18.088 21.436 229 935 2.810
Inventories - 0 0 0 0 0 0 0 0 0
Receivables - 0 405 12 0 0 0 110 0 0
Cash - 2.394 6.304 7.735 13.639 18.088 21.436 119 935 2.810
Shareholders Funds - 2.418 7.700 8.522 14.137 18.420 21.287 -4.813 -8.482 -6.962
Social Capital - 45 44 43 42 41 40 41 40 40
Debts - 80 53 0 210 38 823 5.093 9.534 9.823
Income in Advance - 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 2.810 euro in 2024 which includes Inventories of 0 euro, Receivables of 0 euro and cash availability of 2.810 euro.
The company's Equity was valued at -6.962 euro, while total Liabilities amounted to 9.823 euro. Equity increased by 1.473 euro, from -8.482 euro in 2023, to -6.962 in 2024.

Risk Reports Prices

Reviews - Neuroval Med Srl

Comments - Neuroval Med Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.